Mubashar S Chughtai Md is categorized under Internal Medicine Doctors in Duquesne, PA and active since 1990.
Mubashar S Chughtai Md was established in 1990, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Mubashar S Chughtai at the company’s single location by writing to 424 Grant Avenue, Duquesne, Pennsylvania PA 15110 or by phoning (412) 469-4100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Mubashar S Chughtai Md |
Contact Person: | Mubashar S Chughtai |
Address: | 424 Grant Avenue, Duquesne, Pennsylvania 15110 |
Phone Number: | (412) 469-4100 |
Website Address: | pa-duquesne.doctors.at |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1990 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Mubashar S Chughtai Md was started in 1990 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mubashar S Chughtai for inquiries that concern Mubashar S Chughtai Md by calling the company number (412) 469-4100, as your correspondence is most welcome. Additionally, the physical location of the single location of Mubashar S Chughtai Md can be found at the coordinates 40.372601,-79.84998 as well as the street address 424 Grant Avenue in Duquesne, Pennsylvania 15110.
For its online presence, you may visit Mubashar S Chughtai Md’s website at pa-duquesne.doctors.at and engage with its social media outlets through on Twitter and on Facebook.